Companies Investors People

Loading

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

Get in Touch

Contact
Request a Demo
Request Data Updates
Add a Company

Research

Companies
Investors
People

aVenture

Download App
Pricing

Resources

Documentation
Use Cases
CLI
MCP
Feature Requests
Sitemap

Member

Backed by

Ask AI about aVenture

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy · Terms of Service

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading

Marc Beer - aVenture Research

Marc Beer

AddedMar 31, 2024

UpdatedOct 15, 2026

Marc Beer

Marc Beer

Founder, Lumenxt

Marc Beer's Career

Biote

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview

aVenture product preview

aVenture product preview

Public$25.5MIrving, TX, US

Board Member· Board

Seaside Therapeutics

$30MCambridge, MA, US

Board Member· Board

Lumenxt

Seed$1.5MBoston, MA, US

Board Member· Board

Founder

Origami Surgical

Seed$4.8MMadison, NJ, US

Board Member· Board

Renovia

Series C$72.3MBoston, MA, US

Board Member· Board

Co-Founder

People Similar to Marc Beer

Mark LittonBoard Member · Lumen Bioscience

Magda MarquetBoard Member · Arcturus Therapeutics Holdings

Jim RobertsCo-Founder · Lumen Bioscience

Richard PratiFounder · Singular Medical Technologies

J. Carter McNabbBoard Member · Catalyst OrthoScience

Leadership at Biote

Gary DonovitzFounder

Similar to Biote

WellcoreAustin, TX, USHormone Optimizationest. 2022WellcoreAustin, TX, US · est. 2022

Wellcore offers personalized hormone optimization programs, backed by science, with painless blood testing.

Vitality RxMalibu, CA, USHealth Platform, Hormone Therapyest. 2021Vitality RxMalibu, CA, US · est. 2021

Vitality Rx: A private, effective men's health platform for hormone biomarker optimization.

Seed · $250k30

Hone HealthNew York City, NY, USHormone Therapy, Mens Healthest. 2018Hone HealthNew York City, NY, US · est. 2018

Hone: Men's optimization clinic for hormone imbalances, offering at-home testing and treatment.

Series A · $5.1M90

Hormones & MeAustin, TX, USHRT, Informationest. 2014Hormones & MeAustin, TX, US · est. 2014

Hormones and Me: Your go-to online platform for all Hormone Replacement Therapy (HRT) information.

Series A · $300k30

Leadership at Seaside Therapeutics

Randall CarpenterFounder

Similar to Seaside Therapeutics

Seelos TherapeuticsNew York City, NY, USBiotech, Therapeuticsest. 1987Seelos TherapeuticsNew York City, NY, US · est. 1987

NY-based Seelos Therapeutics, Inc. is a biotech firm developing treatments for stress and depressive disorders.

Public · $65.3M16

Sea PharmaceuticalsCambridge, MA, USPharmaceuticalsest. 2013Sea PharmaceuticalsCambridge, MA, US · est. 2013

Sea Pharmaceuticals develops innovative oral treatments for neurological disorders like tinnitus and epilepsy.

Chase TherapeuticsWashington, D.C., DC, USPharmaceuticalsest. 2017Chase TherapeuticsWashington, D.C., DC, US · est. 2017

Chase Therapeutics: An early-stage pharmaceutical company innovating superior brain disease treatments.

Series B · $25.3M175

Confluence PharmaceuticalsIndianapolis, IN, USPharmaceuticalsest. 2010Confluence PharmaceuticalsIndianapolis, IN, US · est. 2010

Confluence Pharmaceuticals: Providing therapeutic treatments for autism and fragile x syndrome in the US.

Pre-Seed · $2M8

Leadership at Lumenxt

Similar to Lumenxt

MezlightMadison, WI, USSurgical Lightingest. 2014MezlightMadison, WI, US · est. 2014

MezLight: Sterile surgical light instrument, an innovative alternative to standard headlamps for open surgeries.

Angel · $100k4

OnLumeMadison, WI, USMedical Devicesest. 2015OnLumeMadison, WI, US · est. 2015

OnLume: Providing intuitive, precise fluorescence image-guided surgery solutions since 2015.

Series A · $13.5M23

Pathy MedicalShelton, CT, USSurgical Illuminationest. 2016Pathy MedicalShelton, CT, US · est. 2016

Pathy Medical innovates surgical illumination with simple, cost-effective devices like the Light Jacket, enhancing surgical precision and ease.

Series A · $4.8M30

Lumed ScienceDenver, CO, USMedical Devicesest. 2013Lumed ScienceDenver, CO, US · est. 2013

Lumed Science Inc.: Innovating dental procedures with our wire-free, high-intensity mouth prop light.

Leadership at Origami Surgical

Patrick CulliganCo-Founder

Sean McNerneyCEO

Teddy SeyedCo-Founder

Similar to Origami Surgical

Revolve SurgicalToronto, Ontario, CASurgical Robotsest. 2019Revolve SurgicalToronto, Ontario, CA · est. 2019

Revolve: Affordable, compact surgical robotics for all operating rooms.

Pre-Seed · $125k7

SurgimatixElk Grove Village, IL, USSurgical Devicesest. 2007SurgimatixElk Grove Village, IL, US · est. 2007

Surgimatix: Innovating surgical devices for enhanced outcomes, leveraging expertise in surgery, engineering, and business.

Think SurgicalFremont, CA, USRobotic Systemsest. 2007Think SurgicalFremont, CA, US · est. 2007

THINK Surgical, a US-based company, innovates active robotic systems for orthopedic surgery.

Series A · $244.2M212

Sharp FluidicsHayward, CA, USSurgical Equipment, Surgical Safetyest. 2014Sharp FluidicsHayward, CA, US · est. 2014

Sharp Fluidics offers a unique suture needle management system for safer, distraction-free surgeries.

Series B · $9.8M8

Leadership at Renovia

Ramon Iglesias MDCo-Founder

Daniel LevangieBoard Member

Tara ButlerBoard Member

Rich AldrichBoard Member

Adam StoneBoard Member

Similar to Renovia

RenalisChicago, IL, USDigital Therapeuticsest. 2017RenalisChicago, IL, US · est. 2017

Renalis: A digital health company innovating pelvic health solutions for improved outcomes.

Pre-Seed · $1.5M18

Axena HealthNewton, MA, USDigital Health, HealthTechest. 2023

Axena HealthNewton, MA, US · est. 2023

Axena Health: A women-led digital health firm innovating pelvic floor disorder solutions.

Series B · $51.8M25

Liv LabsChicago, IL, USHealth Coachingest. 2017Liv LabsChicago, IL, US · est. 2017

Liv Labs: Innovating self-care for urinary incontinence with tech and services.

Pre-Seed · $2.5M12

FlyteMinneapolis, MN, USMedical Devicesest. 2016FlyteMinneapolis, MN, US · est. 2016

Flyte: A femtech leader in home-based solutions for bladder leaks and pelvic floor strengthening.

Seed · $4.5M30